WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'5801 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 7'0691 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 6'297  6'256  6'218  6'183  6'152  5'959  5'344  4'661 
Births 128  127  127  127  127  146  170  176 
Surviving infants 125  125  125  125  124  143  163  161 
Pop. less than 5 years 639  636  621  617  609  777  791  784 
Pop. less than 15 years 1'934  1'967  1'995  2'029  2'059  2'282  2'227  2'107 
Female 15-49 years 1'770  1'744  1'720  1'695  1'671  1'499  1'287  1'058 

Number of reported case

(Click for retrospective incidence data for El Salvador)
Diphtheria
Japanese encephalitis
Measles 2'315 
Mumps 351  632  369  126  313  1'170 
Pertussis 37  1'003 
Polio* 55 
Rubella 298 
Rubella (CRS)
Tetanus (neonatal) 25  61 
Tetanus (total) 10  13  98 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for El Salvador)
Vaccine year result method % card seen                                                
BCG          90  91  89  87  99  99  75  56 
DTP1 1984  88  DHS   75.3  92  99*  90  90  94  87 
DTP3          92  89  92  91  98  99  80  44 
HepB_BD          87  99* 
HepB3          92  90  89  91  98  99 
Hib3          92  90  89  91  98 
JapEnc         
MCV          93  89  91  95  95  97  98  45 
MCV2          95  82  83  79 
PCV1          93  77 
PCV3          59 
Pol3          92  89  89  91  98  98  80  42 
Rota1          93  90  90  77  85 
Rota_last          93  90  92  61  83 
Rubella1          93  89  91  95  95 
TT2plus          70  68  90  88  26 
PAB         
VAD1          10  42 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for El Salvador)
BCG 90  91  89  87  99  99  75  56 
DTP1 92  90  97  97  99  99  93  69 
DTP3 92  89  92  91  98  99  80  44 
HepB3 92  90  92  91  98  99 
Hib3 92  90  92  91  98 
MCV 93  89  92  95  95  97  98  45 
PAB 90  88  88  87  87  83  37  23 
PCV3 97  67  59 
Pol3 92  89  92  91  98  98  80  42 
Rota_last 93  90  92  61  83 

Number of districts in the country 262  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 65
From 80 to 89% 19
From 50 to 79% 14
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 15-18 months; 4 years; risk groups
DTwP 4 years; Yes
DTwPHibHep 2, 4, 6, 15 months; Yes
HepB HCW and risk groups
IPV 2, 4, 12 months; Yes HIV patients
Influenza 6-59 months; >60 years; Yes and risk groups and PW
MMR 12 months; 4 years; Yes
OPV 2, 4, 6, 15-18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 60 years; HCW and risk groups
Rotavirus 2, 4 months; Yes
Td every 10 years
YF Travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2009-2014  2009-2014  2009-2013    2004-2009  2004-2009  2004-2009 
Nº of districts with microplans that include activities to raise immunization coverage number 262  262  262  262  262  262  262 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 262      262  262  262  262 
Nº districts with DTP3 coverage >=80% number 221      224  224  145  137 
% of districts with DTP3 coverage >=80% From 0 to 100% 84      85  85  55  52 
Nº districts with measles (MCV1) coverage >=95% number 150  119  101  155  138     
% of districts with MCV1 coverage >=95% From 0 to 100% 57      59  53     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100    100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.